Stock search

Ticker or company name

Waters Corporation

WAT · NYSE · Life Sciences Tools & Services

$453,42Down −6,83 (−1,48%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$45,5 bn
Div. yield
—
Year to date
+21,2%
52 weeks: $282,77$483,33

Ratio score

29/100
Ratio would not consider buying

based on 7 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

2 ✓ · 0 — · 5 ✕ · 3 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM269,030,537,9
Forward P/E30,0—29,5
PEGn/a—3,7
P/S9,66,96,6
EV/EBITDA65,725,129,9
P/FCF101,5—38,7
P/B2,916,65,4

Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 28 analysts

Buy
21
Hold
7
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20264,044,10Up +1,6%
Q2 20263,043,05Up +0,4%
Q1 20262,362,70Up +14,4%
Q4 20254,554,53Down −0,5%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q3'25Q2'25Q2'25Q1'25Q1'25Q4'24Q3'24
Revenue1,77 bn1,65 bn1,27 bn932 m800 m800 m771 m771 m662 m662 m873 m740 m
EPS0,82−1,39−0,873,772,502,502,472,472,032,033,882,71
Margin4,6%−8,3%−5,7%24,2%18,6%18,6%19,1%19,1%18,3%18,3%26,5%21,8%
FCF54,0 m153 m−42,0 m126 m162 m162 m18,1 m18,1 m234 m234 m240 m205 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $451 070 (2 people), sales $1,44 m.

NameAmountSharesPrice
kuebler christopher a6 Aug 2026 · sale$1,44 m3 626$397,94
jiang wei16 Mar 2026 · open-market purchase$144 730500$289,46
fearon richard h6 Mar 2026 · open-market purchase$306 3401 000$306,34

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Life Sciences Tools & Services
Exchange
NYSE
Country
US
IPO date
17 Nov 1995

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
IQVIQVIA$264,7372would consider31,3+8,8%8,1%
AAgilent Technologies$172,9278would consider34,1+8,6%19,5%
MTDMettler Toledo$1 727,2663would watch36,5+6,5%22,2%
ILMNIllumina, Inc.$198,0075would consider33,6+5,8%19,7%
WSTWest Pharmaceutical Services$417,8083would consider45,5+12,6%18,8%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.